Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @NeuroTrialsAus
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NeuroTrialsAus
-
Prikvačeni tweet
Did you know? Of the 13 new drugs approved by the FDA in 2016, 7 had Phase III trials conducted in Australia. Read about the takeaway messages from our
#JPM20 Fireside Chat about the Australian clinical trial advantage http://bit.ly/2vsXYlt#clinicaltrialspic.twitter.com/VWpJPJFP4M
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Australia is globally recognised for clinical research capabilities & healthcare infrastructure. Watch this video from
@Austrade & find out why Australia is your next clinical trial destination.https://youtu.be/oUUAQUn8vXIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Victoria has a world class medical technologies and pharmaceutical industry and it's largely due to innovative researchers like Thomas Ko from
@MonashUni https://lens.monash.edu/@monash-life/2019/10/26/1377477/leader-of-the-pharmaceutical-pack …#MonashLensHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
This special issue
will be freely available only until Feb 14! Get access before then to read the illuminating articles at: http://bit.ly/JAD72-s1 // #journalAD#healthyaging#dementia#alzheimers#ADresearchhttps://twitter.com/journal_ad/status/1216811637275009025 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Interested in clinical research but unsure of the path to get there?
@DrSoulis of@NeuroTrialsAus recommends 3 steps to make clinical research your career in our latest blog post. Read here: http://bit.ly/3aMXo1Y pic.twitter.com/3RZZrCV6pY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Speaker Announcement! Read more about the esteemed line-up of industry experts for our 8th Annual Devices and Diagnostics Lab. https://biomelbournenetwork.zohobackstage.com/DevicesDiagnosticsLab2020#/speakers?lang=en …
#DDL2020pic.twitter.com/6aDcc55rJ6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Earlybird discounts for the Bayesian Adaptive Randomised
#ClinicalTrials Workshop have been extended to Fri 7 Feb. Join international experts on adaptive trials, Lorenzo Trippa & Steffen Ventz from@HarvardChanSPH In Melbourne 27-28 Feb and Sydney 5-6 Mar:https://buff.ly/398kPkZHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
#IMNISleader and industry mentor Dr Tina Soulis (@DrSoulis) shares her advice on how to have a successful and rewarding career in clinical research. Dr Soulis is CEO@NeuroTrialsAus and is based in Melbourne#careers#skills#networking#mentoring#IMNIS https://twitter.com/NeuroTrialsAus/status/1222969003095789569 …pic.twitter.com/2kp1Dbhzsi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Our industry-led, VC-backed Accelerator Program brings radical new tech to Australian and international markets. If you have a prototype in bionics, devices, diagnostics, implants, instrumentation, AI, digital health or services, apply now at https://bit.ly/2NcWsKi !
#GdayMedTechpic.twitter.com/UYMroDSAjO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
We are excited to kick off our 2020 free public lecture series on the 12th of February with our special international guest lecturer, Dr Tracy Bale from
@TheBaleLab. Join us to learn about the role of#stress and#trauma in disease across generations! https://www.florey.edu.au/events/transmitting-stress-and-trauma-across-generations?fbclid=IwAR2tXxoMoBclmIXcP5venVfOwAYNw4gpe8PLk9VgHo1XwLd-s9ute4s6glE …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What is the best advice to students thinking about clinical research? Our CEO
@DrSoulis spoke to@FloreyStroke about the opportunities and entry points, and shares her top hints for working in the sector http://bit.ly/38O8lOX pic.twitter.com/v2BccqzFzv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
ONLINE FIRST: Review of the advances and challenges in stroke rehabilitation: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30415-6/fulltext …
@StrokeSciencepic.twitter.com/iu120dhnC4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
If you are active in the
#healthcare or#medtech industry & have an#innovative idea, a device in development or a product ready for market, then our 1 day symposium “Devices + Diagnostics Lab: Manufacturing, Markets & Minefields" is for you https://biomelbourne.org/event/8th-annual-devices-diagnostics-lab/ …#DDL2020pic.twitter.com/3A9s0CUjLcHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Decentralized clinical trials may be the key to improving participant diversity and overcoming recruitment challenges. CROs can ease challenges that come with these trials. http://bit.ly/38LEyXd pic.twitter.com/KF3purb35s
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Interested in
#commercialisation? The@BridgeTech_ Program trains researchers on how to take new#medtech to market. Applications close 31 Jan, so be quick! Apply now: https://research.qut.edu.au/bridgetech/2020-bridgetech-applications/ …pic.twitter.com/JO744bppFv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Huge congratulations to Professor Justin Yerbury AM on his
#australiaday2020 award for significant services to education and research in the field of biological sciences. Very well deserved recognition@jjyerbury


#MND#ALS#research#advocacyhttps://www.illawarramercury.com.au/story/6593929/top-australia-day-honour-for-wollongong-professor-justin-yerbury/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
It takes a village to raise a
#startup – and the industry leaders in our 15-month, VC-backed Accelerator Program will help your#MedTech startup achieve in 15 months what can typically take 3 years. Apply now at https://bit.ly/2NcWsKi !#GdayMedTech@OpylAIpic.twitter.com/o63pdVK3HG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Three neuroprotective drugs fail to show efficacy in secondary progressive multiple sclerosishttps://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30485-5/fulltext?rss=yes …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
From improving RNA analysis to decoding the microbiome, these are the technologies to watch in 2020.https://go.nature.com/2tFZfVL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neuroscience Trials proslijedio/la je Tweet
Save the date! Feb 25, 2020; Melbourne. We're bringing together
#stroke survivors, researchers & clinicians to workshop strategies for improving inclusion and diversity across the process of stroke research. More to come
pic.twitter.com/UZL5qlsEzI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
this issue is freely available!